BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 19457680)

  • 1. Serum factors potentiate hypoxia-induced hepatotoxicity in vitro through increasing transforming growth factor-beta1 activation and release.
    Kao YH; Jawan B; Goto S; Pan MC; Lin YC; Sun CK; Hsu LW; Tai MH; Cheng YF; Nakano T; Wang CS; Huang CJ; Chen CL
    Cytokine; 2009 Jul; 47(1):11-22. PubMed ID: 19457680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
    J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt.
    Ju EM; Choi KC; Hong SH; Lee CH; Kim BC; Kim SJ; Kim IH; Park SH
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1170-81. PubMed ID: 15708000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
    Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
    Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
    Budasz-Rwiderska M; Jank M; Motyl T
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets possess functional TGF-beta receptors and Smad2 protein.
    Lev PR; Salim JP; Marta RF; Osorio MJ; Goette NP; Molinas FC
    Platelets; 2007 Feb; 18(1):35-42. PubMed ID: 17365852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased toxicity by transforming growth factor-beta 1 in liver cells overexpressing CYP2E1.
    Zhuge J; Cederbaum AI
    Free Radic Biol Med; 2006 Oct; 41(7):1100-12. PubMed ID: 16962935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosylphosphorylcholine stimulates expression of fibronectin through TGF-beta1-Smad-dependent mechanism in human mesenchymal stem cells.
    Moon HJ; Jeon ES; Kim YM; Lee MJ; Oh CK; Kim JH
    Int J Biochem Cell Biol; 2007; 39(6):1224-34. PubMed ID: 17481939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.
    Vega JL; Puebla C; Vásquez R; Farías M; Alarcón J; Pastor-Anglada M; Krause B; Casanello P; Sobrevia L
    Cardiovasc Res; 2009 Jun; 82(3):458-67. PubMed ID: 19193655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
    Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression.
    Belaguli NS; Zhang M; Rigi M; Aftab M; Berger DH
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1520-33. PubMed ID: 17290010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes.
    Solá S; Amaral JD; Castro RE; Ramalho RM; Borralho PM; Kren BT; Tanaka H; Steer CJ; Rodrigues CM
    Hepatology; 2005 Oct; 42(4):925-34. PubMed ID: 16175607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
    Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
    Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
    Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
    Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.